Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Влияние курения на развитие поражений плаценты
Влияние курения на развитие поражений плаценты
Щеголев А.И., Туманова У.Н., Мишнёв О.Д. Влияние курения на развитие поражений плаценты. Гинекология. 2018; 20 (2): 34–40.
DOI: 10.26442/2079-5696_2018.2.34-40
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Приведен анализ данных литературы о влиянии курения на развитие поражений плаценты и осложнений беременности. В основе неблагоприятного действия курения на морфофункциональное состояние плаценты лежат выделяющиеся при курении токсические вещества. Нарушения развития плаценты отмечаются как при активном, так и при пассивном курении, при курении до беременности и во время нее. Курение и табачный дым способствуют более частому развитию выкидыша, хориоамнионита, нарушениям васкуляризации ворсин хориона, предлежания и отслойки плаценты, преждевременного разрыва плодных оболочек, что делает необходимым констатацию факта курения беременной в клиническом диагнозе. Вместе с тем курение относится к предотвратимым факторам риска развития осложнений беременности и плода.
Ключевые слова: курение, табак, беременность, плацента, предлежание плаценты, отслойка плаценты, преэклампсия, перинатальная смерть.
Key words: smoking, tobacco, pregnancy, placenta, placenta previa, abruptio placentae, preeclampsia, perinatal death.
Ключевые слова: курение, табак, беременность, плацента, предлежание плаценты, отслойка плаценты, преэклампсия, перинатальная смерть.
________________________________________________
Key words: smoking, tobacco, pregnancy, placenta, placenta previa, abruptio placentae, preeclampsia, perinatal death.
Полный текст
Список литературы
1. Сахарова Г.М., Антонов Н.С. Вредное воздействие табакокурения на здоровье и подходы к лечению табачной зависимости. Справочник поликлинического врача. 2008; 14–15: 16–20. / Sakharova G.M., Antonov N.S. Harmful effects of tobacco Smoking on health and treatment of tobacco dependence. Handbook for Practitioners Doctors. 2008; 14–15: 16–20. [in Russian]
2. Shafey O, Eriksen MP, Ross H et al. The tobacco atlas, 3rd edn. Atlanta, GA: American Cancer Society and World Lung Foundation. 2009.
3. Centers for Disease Control and Prevention, Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. State Prenatal Smoking Databook, 1999. CDC, 2002; p. 14–7.
4. Kirkland SA, Dodds LA, Brosky G. The natural history of smoking during pregnancy among women in Nova Scotia. CMAJ 2000; 163: 281–2.
5. Kilbane S, Knudston E, Vesha K. Smoking cessation in women. Prim. Care Update Obstet Gynecol 2002; 9: 164–8.
6. American College of Obstetricians and Gynecologists. Smoking and Women’s Health. ACOG Educational Bulletin 240. Washington, DC: ACOG, 1997.
7. Fildinq JE. Smoking and women: Tragedy of the majority. New Engl J Med 2006; 317: 1343–5.
8. Камардина Т.В. Современное состояние проблемы табакокурения и возможные пути ее решения. Общественное здоровье и профилактика заболеваний. 2004; 5: 46. / Kamardina T.V. Sovremennoe sostoianie problemy tabakokureniia i vozmozhnye puti ee resheniia. Obshchestvennoe zdorov'e i profilaktika zabolevanii. 2004; 5: 46. [in Russian]
9. Öberg M, Woodward A, Jaakkola MS et al. Global estimate of the burden of disease from second-hand smoke. Geneva, World Health Organization, 2010.
10. Кузина О.А., Щетинина Ю.С., Зинченко Е.А. К проблеме курения при беременности. Теория и практика актуальных исследований. 2016; 11: 119–26. / Kuzina O.A., Shchetinina Iu.S., Zinchenko E.A. K probleme kureniia pri beremennosti. Teoriia i praktika aktual'nykh issledovanii. 2016; 11: 119–26. [in Russian]
11. Parran TV. The physician’s role in smoking cessation. J Respir Dis 1998; 19: S6–12.
12. Rodgman A, Perfetti T. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, 2009; p. 1483–784.
13. Talbot P, Riveles K. Smoking and reproduction: The oviduct as a target of cigarette smoke. Reprod Biol Endocrinol 2005; 3: 52.
14. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control 2005; 14: 396–404.
15. Berlin I, Heilbronner C, Georgieu S et al. Newborns’ cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug Alcohol Depend 2010; 107: 250–2.
16. Lindbohm M-L, Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002; 28: 84–96.
17. Wu FY, Chiu HT, Wu HDI et al. Comparison of urinary and plasma cotinine levels during the three trimesters of pregnancy. Paediatr Perinatal Epidemiol 2008; 22: 296–301.
18. Kharrazi M, DeLorenze GN, Kaufman FL et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 2004; 15: 660–70.
19. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989; 129: 1072–8.
20. Jensen TK, Henriksen TB, Hjollund NHI et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998; 148: 992–7.
21. Hull MGR, North K, Taylor H et al. Delayed conception and active and passive smoking. Fertil Steril 2000; 74: 725–33.
22. Daling JR. Cigarette smoking and primary tubal infertility. In Smoking and Reproductive Health. Ed by: M.J.R.Littleton. MA, PSG Publishers. 1987; p. 40–6.
23. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 19: S81–S86.
24. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch. B Cell Pathol Incl Mol Patho 1991; 60: 365–72.
25. Salmasi G, Grady R, Jones J et al. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol 2010; 89: 423–1.
26. Сидорова И.С., Макаров И.О. Клинико-диагностические аспекты фетоплацентарной недостаточности. М.: МИА, 2005. / Sidorova I.S., Makarov I.O. Kliniko-diagnosticheskie aspekty fetoplatsentarnoi nedostatochnosti. M.: MIA, 2005. [in Russian]
27. Щеголев А.И. Современная морфологическая классификация повреждений плаценты. Акушерство и гинекология. 2016; 4: 16–23. / Shchegolev A.I. Sovremennaia morfologicheskaia klassifikatsiia povrezhdenii platsenty. Akusherstvo i ginekologiia. 2016; 4: 16–23. [in Russian]
28. Грызунова Е.М., Совершаева С.Л., Соловьев А.Г. и др. Состояние гемодинамики в системе «мать – плацента – плод» у курящих беременных. Экология человека. 2016; 9: 15–20. / Gryzunova E.M., Sovershaeva S.L., Solov'ev A.G. i dr. Sostoianie gemodinamiki v sisteme “mat' – platsenta – plod” u kuriashchikh beremennykh. Ekologiia cheloveka. 2016; 9: 15–20. [in Russian]
29. Bureau MA, Monette J, Shapcott D et al. Carboxy haemoglobin concentration in fetal cord blood and in blood of mothers who smoked during labor. Pediatrics 1982; 69: 371–3.
30. Mayhew TM, Jackson MR, Haas JD. Oxygen diffusive conductances of human placentae from term pregnancies at low and high altitudes. Placenta 1990; 11: 493–503.
31. Bush G, Mayhew TM, Abramovich DR et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56.
32. Van der Velde WJ, Copius-Peereboom Stegman JH, Treffers PE, James J. Structural changes in the placenta of smoking mothers: a quantitative study. Placenta 1983; 4: 231–40.
33. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96: 907–15.
34. Larsen LG, Clausen HV, Jønsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 2002; 186: 531–7.
35. Zhao H, Wu L, Wang Y et al. Nicotine promotes vascular endothelial growth factor secretion by human trophoblast cells under hypoxic conditions and improves the proliferation and tube formation capacity of human umbilical endothelial cells. Reprod Bio Med Online 2017; 34: 406–13.
36. Fan X, Rai A, Kambham N et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 2014; 124: 4941–52.
37. Павлов К.А., Дубова Е.А., Щеголев А.И. Фетоплацентарный ангиогенез при нормальной беременности: роль плацентарного фактора роста и ангиопоэтинов. Акушерство и гинекология. 2010; 6: 10–5. / Pavlov K.A., Dubova E.A., Shchegolev A.I. Fetoplatsentarnyi angiogenez pri normal'noi beremennosti: rol' platsentarnogo faktora rosta i angiopoetinov. Akusherstvo i ginekologiia. 2010; 6: 10–5. [in Russian]
38. Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 2007; 197 (363): e1–e5.
39. Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000; 57: 207–13.
40. Wei J, Liu CX, Gong TT et al. Cigarette smoking during pregnancy and pre-eclampsia risk: a systematic review and meta-analysis of prospective studies. Oncotarget 2015; 6: 43667–78.
41. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010; 5: 1254–9.
42. Mayhew TM, Ohadike C, Baker PN et al. Stereological investigation of placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. Placenta 2003; 24: 219–26.
43. Щеголев А.И., Дубова Е.А., Павлов К.А. и др. Морфометрическая характеристика терминальных ворсин плаценты при преэклампсии. Бюл. эксперим. биологии и медицины. 2012; 7: 104–7. / Shchegolev A.I., Dubova E.A., Pavlov K.A. i dr. Morfometricheskaia kharakteristika terminal'nykh vorsin platsenty pri preeklampsii. Biul. eksperim. biologii i meditsiny. 2012; 7: 104–7. [in Russian]
44. Воднева Д.Н., Романова В.В., Дубова Е.А. и др. Клинико-морфологические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2014; 2: 35–40. / Vodneva D.N., Romanova V.V., Dubova E.A. i dr. Kliniko-morfologicheskie osobennosti rannei i pozdnei preeklampsii. Akusherstvo i ginekologiia. 2014; 2: 35–40.
[in Russian]
45. Щеголев А.И., Ляпин В.М., Туманова У.Н. и др. Гистологические изменения плаценты и васкуляризация ее ворсин при ранней и поздней преэклампсии. Архив патологии. 2016; 1: 13–8. / Shchegolev A.I., Liapin V.M., Tumanova U.N. i dr. Gistologicheskie izmeneniia platsenty i vaskuliarizatsiia ee vorsin pri rannei i pozdnei preeklampsii. Arkhiv patologii. 2016; 1: 13–8. [in Russian]
46. Sabra S, Gratacós E, Roig MDG. Smoking-induced changes in the maternal immune, endocrine, and metabolic pathways and their impact on fetal growth: A topical review. Fetal Diagn Ther 2017; 41; 241–50.
47. Hayashi K, Matsuda Y, Kawamichi Y et al. Smoking during pregnancy increases risks of various obstetric complications: A case-cohort study of the Japan Perinatal Registry Network Database. J Epidemiol 2011; 21: 61–6.
48. Hammoud AO, Bujold E, Sorokin Y et al. Smoking in pregnancy revisited: Findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856–63.
49. Comeau J, Shaw L, Marcell C, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983; 61: 577–80.
50. McShane P, Heyl P, Epstein M. Maternal and perinatal morbidity resulting from placental previa. Obstet Gynecol 1985; 65: 176–82.
51. Щеголев А.И., Туманова У.Н., Фролова О.Г. Региональные особенности мертворождаемости в Российской Федерации. Актуальные вопросы судебно-медицинской экспертизы и экспертной практики в региональных бюро судебно-медицинской экспертизы на современном этапе. Рязань, 2013; с. 163–9. / Shchegolev A.I., Tumanova U.N., Frolova O.G. Regional'nye osobennosti mertvorozhdaemosti v Rossiiskoi Federatsii. Aktual'nye voprosy sudebno-meditsinskoi ekspertizy i ekspertnoi praktiki v regional'nykh biuro sudebno-meditsinskoi ekspertizy na sovremennom etape. Riazan', 2013; s. 163–9. [in Russian]
52. Hung TH, Hsieh CC, Hsu JJ et al. Risk factors for placenta previa in an Asian population. Int J Gynaecol Obstet 2007; 97: 26–30.
53. Thomas AG, Alvarez M, Friedman FJr et al. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 1994; 84: 58–60.
54. Matsuda Y, Hayashi K, Shiozaki A et al. Comparison of risk factors for placental abruption and placenta previa: case-cohort study. J Obstet Gynaecol Res 2011; 37: 538–46.
55. Shobeiri F, Jenabi E. Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 2017; 30: 2985–90.
56. Krohn M, Voigt L, McKnight B et al. Correlates of placental abruption. Br J Obstet Gynaecol 1987; 94: 333–40.
57. Щеголев А.И., Туманова У.Н., Шувалова М.П., Фролова О.Г. Гипоксия как причина мертворождаемости в Российской Федерации. Здоровье, демография, экология финно-угорских народов. 2014; 3: 96–8. / Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Gipoksiia kak prichina mertvorozhdaemosti v Rossiiskoi Federatsii. Zdorov'e, demografiia, ekologiia finno-ugorskikh narodov. 2014; 3: 96–8. [in Russian]
58. Туманова У.Н., Шувалова М.П., Щеголев А.И. Роль преждевременной отслойки плаценты в генезе ранней неонатальной смерти. Неонатология: новости, мнения, обучение. 2016; 4: 70–5. / Tumanova U.N., Shuvalova M.P., Shchegolev A.I. Rol' prezhdevremennoi otsloiki platsenty v geneze rannei neonatal'noi smerti. Neonatologiia: novosti, mneniia, obuchenie. 2016; 4: 70–5. [in Russian]
59. Meyer M, Tonascia J. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol 1976; 1103: 464–76.
60. Shubert J, Diss E, Iams J. Etiology of preterm premature rupture of the membranes. Obstet Gynecol Clin North Am 1992; 19: 251–63.
61. Hadley C, Main D, Gabbe S. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990; 7: 374–9.
62. Meyer M, Tonascia J. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977; 128: 494–502.
63. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol 1998; 179: 1051–5.
64. Семенова Т.В., Аржанова О.Н., Беспалова О.Н. и др. Особенности течения беременности и исходов родов при табакокурении. Журн. акушерства и женских болезней. 2014; 2: 50–8. / Semenova T.V., Arzhanova O.N., Bespalova O.N. i dr. Osobennosti techeniia beremennosti i iskhodov rodov pri tabakokurenii. Zhurn. akusherstva i zhenskikh boleznei. 2014; 2: 50–8. [in Russian]
65. Klesges LM, Murray DM, Brown JE et al. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am J Epidemiol 1998; 147: 127–35.
66. Marana HRC, Andrade JM, Martins GA et al. A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynecol Obstet 1998; 61: 21–7.
67. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: a light and electron microscopic study. Placenta 1982; 3: 243–56.
68. Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother. A quantitative and ultrastructural study. Pathol Res Pract 1994; 190: 656–67.
69. Salafia CM, Zhang J, Charles AK et al. Prenatal characteristics and birthweight. Paediatr Perinatal Epidemiol 2008; 22: 229–39.
70. Ganer Herman H, Miremberg H, Nini N et al. The effects of maternal smoking on pregnancy outcome and placental histopathology lesions. Reprod Toxicol 2016; 65: 24–8.
71. Johnstone FD. Smoke screen around the fetus. Lancet 1990; 335: 361.
72. Haworth JC, Ellestad-Sayed JJ, King J et al. Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake. Am J Obstet Gynecol 1980; 137: 719–23.
73. Blair PS, Fleming PJ, Bensley D et al. Smoking and sudden infant deathsyndrome: results from 1993–5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J 1996; 313: 195–8.
2. Shafey O, Eriksen MP, Ross H et al. The tobacco atlas, 3rd edn. Atlanta, GA: American Cancer Society and World Lung Foundation. 2009.
3. Centers for Disease Control and Prevention, Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. State Prenatal Smoking Databook, 1999. CDC, 2002; p. 14–7.
4. Kirkland SA, Dodds LA, Brosky G. The natural history of smoking during pregnancy among women in Nova Scotia. CMAJ 2000; 163: 281–2.
5. Kilbane S, Knudston E, Vesha K. Smoking cessation in women. Prim. Care Update Obstet Gynecol 2002; 9: 164–8.
6. American College of Obstetricians and Gynecologists. Smoking and Women’s Health. ACOG Educational Bulletin 240. Washington, DC: ACOG, 1997.
7. Fildinq JE. Smoking and women: Tragedy of the majority. New Engl J Med 2006; 317: 1343–5.
8. Kamardina T.V. Sovremennoe sostoianie problemy tabakokureniia i vozmozhnye puti ee resheniia. Obshchestvennoe zdorov'e i profilaktika zabolevanii. 2004; 5: 46. [in Russian]
9. Öberg M, Woodward A, Jaakkola MS et al. Global estimate of the burden of disease from second-hand smoke. Geneva, World Health Organization, 2010.
10. Kuzina O.A., Shchetinina Iu.S., Zinchenko E.A. K probleme kureniia pri beremennosti. Teoriia i praktika aktual'nykh issledovanii. 2016; 11: 119–26. [in Russian]
11. Parran TV. The physician’s role in smoking cessation. J Respir Dis 1998; 19: S6–12.
12. Rodgman A, Perfetti T. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, 2009; p. 1483–784.
13. Talbot P, Riveles K. Smoking and reproduction: The oviduct as a target of cigarette smoke. Reprod Biol Endocrinol 2005; 3: 52.
14. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control 2005; 14: 396–404.
15. Berlin I, Heilbronner C, Georgieu S et al. Newborns’ cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug Alcohol Depend 2010; 107: 250–2.
16. Lindbohm M-L, Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002; 28: 84–96.
17. Wu FY, Chiu HT, Wu HDI et al. Comparison of urinary and plasma cotinine levels during the three trimesters of pregnancy. Paediatr Perinatal Epidemiol 2008; 22: 296–301.
18. Kharrazi M, DeLorenze GN, Kaufman FL et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 2004; 15: 660–70.
19. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989; 129: 1072–8.
20. Jensen TK, Henriksen TB, Hjollund NHI et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998; 148: 992–7.
21. Hull MGR, North K, Taylor H et al. Delayed conception and active and passive smoking. Fertil Steril 2000; 74: 725–33.
22. Daling JR. Cigarette smoking and primary tubal infertility. In Smoking and Reproductive Health. Ed by: M.J.R.Littleton. MA, PSG Publishers. 1987; p. 40–6.
23. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 19: S81–S86.
24. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch. B Cell Pathol Incl Mol Patho 1991; 60: 365–72.
25. Salmasi G, Grady R, Jones J et al. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol 2010; 89: 423–1.
26. Sidorova I.S., Makarov I.O. Kliniko-diagnosticheskie aspekty fetoplatsentarnoi nedostatochnosti. M.: MIA, 2005. [in Russian]
27. Shchegolev A.I. Sovremennaia morfologicheskaia klassifikatsiia povrezhdenii platsenty. Akusherstvo i ginekologiia. 2016; 4: 16–23. [in Russian]
28. Gryzunova E.M., Sovershaeva S.L., Solov'ev A.G. i dr. Sostoianie gemodinamiki v sisteme “mat' – platsenta – plod” u kuriashchikh beremennykh. Ekologiia cheloveka. 2016; 9: 15–20. [in Russian]
29. Bureau MA, Monette J, Shapcott D et al. Carboxy haemoglobin concentration in fetal cord blood and in blood of mothers who smoked during labor. Pediatrics 1982; 69: 371–3.
30. Mayhew TM, Jackson MR, Haas JD. Oxygen diffusive conductances of human placentae from term pregnancies at low and high altitudes. Placenta 1990; 11: 493–503.
31. Bush G, Mayhew TM, Abramovich DR et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56.
32. Van der Velde WJ, Copius-Peereboom Stegman JH, Treffers PE, James J. Structural changes in the placenta of smoking mothers: a quantitative study. Placenta 1983; 4: 231–40.
33. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96: 907–15.
34. Larsen LG, Clausen HV, Jønsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 2002; 186: 531–7.
35. Zhao H, Wu L, Wang Y et al. Nicotine promotes vascular endothelial growth factor secretion by human trophoblast cells under hypoxic conditions and improves the proliferation and tube formation capacity of human umbilical endothelial cells. Reprod Bio Med Online 2017; 34: 406–13.
36. Fan X, Rai A, Kambham N et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 2014; 124: 4941–52.
37. Pavlov K.A., Dubova E.A., Shchegolev A.I. Fetoplatsentarnyi angiogenez pri normal'noi beremennosti: rol' platsentarnogo faktora rosta i angiopoetinov. Akusherstvo i ginekologiia. 2010; 6: 10–5. [in Russian]
38. Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 2007; 197 (363): e1–e5.
39. Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000; 57: 207–13.
40. Wei J, Liu CX, Gong TT et al. Cigarette smoking during pregnancy and pre-eclampsia risk: a systematic review and meta-analysis of prospective studies. Oncotarget 2015; 6: 43667–78.
41. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010; 5: 1254–9.
42. Mayhew TM, Ohadike C, Baker PN et al. Stereological investigation of placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. Placenta 2003; 24: 219–26.
43. Shchegolev A.I., Dubova E.A., Pavlov K.A. i dr. Morfometricheskaia kharakteristika terminal'nykh vorsin platsenty pri preeklampsii. Biul. eksperim. biologii i meditsiny. 2012; 7: 104–7. [in Russian]
44. Vodneva D.N., Romanova V.V., Dubova E.A. i dr. Kliniko-morfologicheskie osobennosti rannei i pozdnei preeklampsii. Akusherstvo i ginekologiia. 2014; 2: 35–40.
[in Russian]
45. Shchegolev A.I., Liapin V.M., Tumanova U.N. i dr. Gistologicheskie izmeneniia platsenty i vaskuliarizatsiia ee vorsin pri rannei i pozdnei preeklampsii. Arkhiv patologii. 2016; 1: 13–8. [in Russian]
46. Sabra S, Gratacós E, Roig MDG. Smoking-induced changes in the maternal immune, endocrine, and metabolic pathways and their impact on fetal growth: A topical review. Fetal Diagn Ther 2017; 41; 241–50.
47. Hayashi K, Matsuda Y, Kawamichi Y et al. Smoking during pregnancy increases risks of various obstetric complications: A case-cohort study of the Japan Perinatal Registry Network Database. J Epidemiol 2011; 21: 61–6.
48. Hammoud AO, Bujold E, Sorokin Y et al. Smoking in pregnancy revisited: Findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856–63.
49. Comeau J, Shaw L, Marcell C, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983; 61: 577–80.
50. McShane P, Heyl P, Epstein M. Maternal and perinatal morbidity resulting from placental previa. Obstet Gynecol 1985; 65: 176–82.
51. Shchegolev A.I., Tumanova U.N., Frolova O.G. Regional'nye osobennosti mertvorozhdaemosti v Rossiiskoi Federatsii. Aktual'nye voprosy sudebno-meditsinskoi ekspertizy i ekspertnoi praktiki v regional'nykh biuro sudebno-meditsinskoi ekspertizy na sovremennom etape. Riazan', 2013; s. 163–9. [in Russian]
52. Hung TH, Hsieh CC, Hsu JJ et al. Risk factors for placenta previa in an Asian population. Int J Gynaecol Obstet 2007; 97: 26–30.
53. Thomas AG, Alvarez M, Friedman FJr et al. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 1994; 84: 58–60.
54. Matsuda Y, Hayashi K, Shiozaki A et al. Comparison of risk factors for placental abruption and placenta previa: case-cohort study. J Obstet Gynaecol Res 2011; 37: 538–46.
55. Shobeiri F, Jenabi E. Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 2017; 30: 2985–90.
56. Krohn M, Voigt L, McKnight B et al. Correlates of placental abruption. Br J Obstet Gynaecol 1987; 94: 333–40.
57. Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Gipoksiia kak prichina mertvorozhdaemosti v Rossiiskoi Federatsii. Zdorov'e, demografiia, ekologiia finno-ugorskikh narodov. 2014; 3: 96–8. [in Russian]
58. Tumanova U.N., Shuvalova M.P., Shchegolev A.I. Rol' prezhdevremennoi otsloiki platsenty v geneze rannei neonatal'noi smerti. Neonatologiia: novosti, mneniia, obuchenie. 2016; 4: 70–5. [in Russian]
59. Meyer M, Tonascia J. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol 1976; 1103: 464–76.
60. Shubert J, Diss E, Iams J. Etiology of preterm premature rupture of the membranes. Obstet Gynecol Clin North Am 1992; 19: 251–63.
61. Hadley C, Main D, Gabbe S. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990; 7: 374–9.
62. Meyer M, Tonascia J. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977; 128: 494–502.
63. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol 1998; 179: 1051–5.
64. Semenova T.V., Arzhanova O.N., Bespalova O.N. i dr. Osobennosti techeniia beremennosti i iskhodov rodov pri tabakokurenii. Zhurn. akusherstva i zhenskikh boleznei. 2014; 2: 50–8. [in Russian]
65. Klesges LM, Murray DM, Brown JE et al. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am J Epidemiol 1998; 147: 127–35.
66. Marana HRC, Andrade JM, Martins GA et al. A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynecol Obstet 1998; 61: 21–7.
67. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: a light and electron microscopic study. Placenta 1982; 3: 243–56.
68. Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother. A quantitative and ultrastructural study. Pathol Res Pract 1994; 190: 656–67.
69. Salafia CM, Zhang J, Charles AK et al. Prenatal characteristics and birthweight. Paediatr Perinatal Epidemiol 2008; 22: 229–39.
70. Ganer Herman H, Miremberg H, Nini N et al. The effects of maternal smoking on pregnancy outcome and placental histopathology lesions. Reprod Toxicol 2016; 65: 24–8.
71. Johnstone FD. Smoke screen around the fetus. Lancet 1990; 335: 361.
72. Haworth JC, Ellestad-Sayed JJ, King J et al. Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake. Am J Obstet Gynecol 1980; 137: 719–23.
73. Blair PS, Fleming PJ, Bensley D et al. Smoking and sudden infant deathsyndrome: results from 1993–5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J 1996; 313: 195–8.
2. Shafey O, Eriksen MP, Ross H et al. The tobacco atlas, 3rd edn. Atlanta, GA: American Cancer Society and World Lung Foundation. 2009.
3. Centers for Disease Control and Prevention, Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. State Prenatal Smoking Databook, 1999. CDC, 2002; p. 14–7.
4. Kirkland SA, Dodds LA, Brosky G. The natural history of smoking during pregnancy among women in Nova Scotia. CMAJ 2000; 163: 281–2.
5. Kilbane S, Knudston E, Vesha K. Smoking cessation in women. Prim. Care Update Obstet Gynecol 2002; 9: 164–8.
6. American College of Obstetricians and Gynecologists. Smoking and Women’s Health. ACOG Educational Bulletin 240. Washington, DC: ACOG, 1997.
7. Fildinq JE. Smoking and women: Tragedy of the majority. New Engl J Med 2006; 317: 1343–5.
8. Камардина Т.В. Современное состояние проблемы табакокурения и возможные пути ее решения. Общественное здоровье и профилактика заболеваний. 2004; 5: 46. / Kamardina T.V. Sovremennoe sostoianie problemy tabakokureniia i vozmozhnye puti ee resheniia. Obshchestvennoe zdorov'e i profilaktika zabolevanii. 2004; 5: 46. [in Russian]
9. Öberg M, Woodward A, Jaakkola MS et al. Global estimate of the burden of disease from second-hand smoke. Geneva, World Health Organization, 2010.
10. Кузина О.А., Щетинина Ю.С., Зинченко Е.А. К проблеме курения при беременности. Теория и практика актуальных исследований. 2016; 11: 119–26. / Kuzina O.A., Shchetinina Iu.S., Zinchenko E.A. K probleme kureniia pri beremennosti. Teoriia i praktika aktual'nykh issledovanii. 2016; 11: 119–26. [in Russian]
11. Parran TV. The physician’s role in smoking cessation. J Respir Dis 1998; 19: S6–12.
12. Rodgman A, Perfetti T. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, 2009; p. 1483–784.
13. Talbot P, Riveles K. Smoking and reproduction: The oviduct as a target of cigarette smoke. Reprod Biol Endocrinol 2005; 3: 52.
14. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control 2005; 14: 396–404.
15. Berlin I, Heilbronner C, Georgieu S et al. Newborns’ cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug Alcohol Depend 2010; 107: 250–2.
16. Lindbohm M-L, Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002; 28: 84–96.
17. Wu FY, Chiu HT, Wu HDI et al. Comparison of urinary and plasma cotinine levels during the three trimesters of pregnancy. Paediatr Perinatal Epidemiol 2008; 22: 296–301.
18. Kharrazi M, DeLorenze GN, Kaufman FL et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 2004; 15: 660–70.
19. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989; 129: 1072–8.
20. Jensen TK, Henriksen TB, Hjollund NHI et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998; 148: 992–7.
21. Hull MGR, North K, Taylor H et al. Delayed conception and active and passive smoking. Fertil Steril 2000; 74: 725–33.
22. Daling JR. Cigarette smoking and primary tubal infertility. In Smoking and Reproductive Health. Ed by: M.J.R.Littleton. MA, PSG Publishers. 1987; p. 40–6.
23. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 19: S81–S86.
24. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch. B Cell Pathol Incl Mol Patho 1991; 60: 365–72.
25. Salmasi G, Grady R, Jones J et al. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol 2010; 89: 423–1.
26. Сидорова И.С., Макаров И.О. Клинико-диагностические аспекты фетоплацентарной недостаточности. М.: МИА, 2005. / Sidorova I.S., Makarov I.O. Kliniko-diagnosticheskie aspekty fetoplatsentarnoi nedostatochnosti. M.: MIA, 2005. [in Russian]
27. Щеголев А.И. Современная морфологическая классификация повреждений плаценты. Акушерство и гинекология. 2016; 4: 16–23. / Shchegolev A.I. Sovremennaia morfologicheskaia klassifikatsiia povrezhdenii platsenty. Akusherstvo i ginekologiia. 2016; 4: 16–23. [in Russian]
28. Грызунова Е.М., Совершаева С.Л., Соловьев А.Г. и др. Состояние гемодинамики в системе «мать – плацента – плод» у курящих беременных. Экология человека. 2016; 9: 15–20. / Gryzunova E.M., Sovershaeva S.L., Solov'ev A.G. i dr. Sostoianie gemodinamiki v sisteme “mat' – platsenta – plod” u kuriashchikh beremennykh. Ekologiia cheloveka. 2016; 9: 15–20. [in Russian]
29. Bureau MA, Monette J, Shapcott D et al. Carboxy haemoglobin concentration in fetal cord blood and in blood of mothers who smoked during labor. Pediatrics 1982; 69: 371–3.
30. Mayhew TM, Jackson MR, Haas JD. Oxygen diffusive conductances of human placentae from term pregnancies at low and high altitudes. Placenta 1990; 11: 493–503.
31. Bush G, Mayhew TM, Abramovich DR et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56.
32. Van der Velde WJ, Copius-Peereboom Stegman JH, Treffers PE, James J. Structural changes in the placenta of smoking mothers: a quantitative study. Placenta 1983; 4: 231–40.
33. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96: 907–15.
34. Larsen LG, Clausen HV, Jønsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 2002; 186: 531–7.
35. Zhao H, Wu L, Wang Y et al. Nicotine promotes vascular endothelial growth factor secretion by human trophoblast cells under hypoxic conditions and improves the proliferation and tube formation capacity of human umbilical endothelial cells. Reprod Bio Med Online 2017; 34: 406–13.
36. Fan X, Rai A, Kambham N et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 2014; 124: 4941–52.
37. Павлов К.А., Дубова Е.А., Щеголев А.И. Фетоплацентарный ангиогенез при нормальной беременности: роль плацентарного фактора роста и ангиопоэтинов. Акушерство и гинекология. 2010; 6: 10–5. / Pavlov K.A., Dubova E.A., Shchegolev A.I. Fetoplatsentarnyi angiogenez pri normal'noi beremennosti: rol' platsentarnogo faktora rosta i angiopoetinov. Akusherstvo i ginekologiia. 2010; 6: 10–5. [in Russian]
38. Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 2007; 197 (363): e1–e5.
39. Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000; 57: 207–13.
40. Wei J, Liu CX, Gong TT et al. Cigarette smoking during pregnancy and pre-eclampsia risk: a systematic review and meta-analysis of prospective studies. Oncotarget 2015; 6: 43667–78.
41. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010; 5: 1254–9.
42. Mayhew TM, Ohadike C, Baker PN et al. Stereological investigation of placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. Placenta 2003; 24: 219–26.
43. Щеголев А.И., Дубова Е.А., Павлов К.А. и др. Морфометрическая характеристика терминальных ворсин плаценты при преэклампсии. Бюл. эксперим. биологии и медицины. 2012; 7: 104–7. / Shchegolev A.I., Dubova E.A., Pavlov K.A. i dr. Morfometricheskaia kharakteristika terminal'nykh vorsin platsenty pri preeklampsii. Biul. eksperim. biologii i meditsiny. 2012; 7: 104–7. [in Russian]
44. Воднева Д.Н., Романова В.В., Дубова Е.А. и др. Клинико-морфологические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2014; 2: 35–40. / Vodneva D.N., Romanova V.V., Dubova E.A. i dr. Kliniko-morfologicheskie osobennosti rannei i pozdnei preeklampsii. Akusherstvo i ginekologiia. 2014; 2: 35–40.
[in Russian]
45. Щеголев А.И., Ляпин В.М., Туманова У.Н. и др. Гистологические изменения плаценты и васкуляризация ее ворсин при ранней и поздней преэклампсии. Архив патологии. 2016; 1: 13–8. / Shchegolev A.I., Liapin V.M., Tumanova U.N. i dr. Gistologicheskie izmeneniia platsenty i vaskuliarizatsiia ee vorsin pri rannei i pozdnei preeklampsii. Arkhiv patologii. 2016; 1: 13–8. [in Russian]
46. Sabra S, Gratacós E, Roig MDG. Smoking-induced changes in the maternal immune, endocrine, and metabolic pathways and their impact on fetal growth: A topical review. Fetal Diagn Ther 2017; 41; 241–50.
47. Hayashi K, Matsuda Y, Kawamichi Y et al. Smoking during pregnancy increases risks of various obstetric complications: A case-cohort study of the Japan Perinatal Registry Network Database. J Epidemiol 2011; 21: 61–6.
48. Hammoud AO, Bujold E, Sorokin Y et al. Smoking in pregnancy revisited: Findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856–63.
49. Comeau J, Shaw L, Marcell C, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983; 61: 577–80.
50. McShane P, Heyl P, Epstein M. Maternal and perinatal morbidity resulting from placental previa. Obstet Gynecol 1985; 65: 176–82.
51. Щеголев А.И., Туманова У.Н., Фролова О.Г. Региональные особенности мертворождаемости в Российской Федерации. Актуальные вопросы судебно-медицинской экспертизы и экспертной практики в региональных бюро судебно-медицинской экспертизы на современном этапе. Рязань, 2013; с. 163–9. / Shchegolev A.I., Tumanova U.N., Frolova O.G. Regional'nye osobennosti mertvorozhdaemosti v Rossiiskoi Federatsii. Aktual'nye voprosy sudebno-meditsinskoi ekspertizy i ekspertnoi praktiki v regional'nykh biuro sudebno-meditsinskoi ekspertizy na sovremennom etape. Riazan', 2013; s. 163–9. [in Russian]
52. Hung TH, Hsieh CC, Hsu JJ et al. Risk factors for placenta previa in an Asian population. Int J Gynaecol Obstet 2007; 97: 26–30.
53. Thomas AG, Alvarez M, Friedman FJr et al. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 1994; 84: 58–60.
54. Matsuda Y, Hayashi K, Shiozaki A et al. Comparison of risk factors for placental abruption and placenta previa: case-cohort study. J Obstet Gynaecol Res 2011; 37: 538–46.
55. Shobeiri F, Jenabi E. Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 2017; 30: 2985–90.
56. Krohn M, Voigt L, McKnight B et al. Correlates of placental abruption. Br J Obstet Gynaecol 1987; 94: 333–40.
57. Щеголев А.И., Туманова У.Н., Шувалова М.П., Фролова О.Г. Гипоксия как причина мертворождаемости в Российской Федерации. Здоровье, демография, экология финно-угорских народов. 2014; 3: 96–8. / Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Gipoksiia kak prichina mertvorozhdaemosti v Rossiiskoi Federatsii. Zdorov'e, demografiia, ekologiia finno-ugorskikh narodov. 2014; 3: 96–8. [in Russian]
58. Туманова У.Н., Шувалова М.П., Щеголев А.И. Роль преждевременной отслойки плаценты в генезе ранней неонатальной смерти. Неонатология: новости, мнения, обучение. 2016; 4: 70–5. / Tumanova U.N., Shuvalova M.P., Shchegolev A.I. Rol' prezhdevremennoi otsloiki platsenty v geneze rannei neonatal'noi smerti. Neonatologiia: novosti, mneniia, obuchenie. 2016; 4: 70–5. [in Russian]
59. Meyer M, Tonascia J. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol 1976; 1103: 464–76.
60. Shubert J, Diss E, Iams J. Etiology of preterm premature rupture of the membranes. Obstet Gynecol Clin North Am 1992; 19: 251–63.
61. Hadley C, Main D, Gabbe S. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990; 7: 374–9.
62. Meyer M, Tonascia J. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977; 128: 494–502.
63. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol 1998; 179: 1051–5.
64. Семенова Т.В., Аржанова О.Н., Беспалова О.Н. и др. Особенности течения беременности и исходов родов при табакокурении. Журн. акушерства и женских болезней. 2014; 2: 50–8. / Semenova T.V., Arzhanova O.N., Bespalova O.N. i dr. Osobennosti techeniia beremennosti i iskhodov rodov pri tabakokurenii. Zhurn. akusherstva i zhenskikh boleznei. 2014; 2: 50–8. [in Russian]
65. Klesges LM, Murray DM, Brown JE et al. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am J Epidemiol 1998; 147: 127–35.
66. Marana HRC, Andrade JM, Martins GA et al. A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynecol Obstet 1998; 61: 21–7.
67. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: a light and electron microscopic study. Placenta 1982; 3: 243–56.
68. Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother. A quantitative and ultrastructural study. Pathol Res Pract 1994; 190: 656–67.
69. Salafia CM, Zhang J, Charles AK et al. Prenatal characteristics and birthweight. Paediatr Perinatal Epidemiol 2008; 22: 229–39.
70. Ganer Herman H, Miremberg H, Nini N et al. The effects of maternal smoking on pregnancy outcome and placental histopathology lesions. Reprod Toxicol 2016; 65: 24–8.
71. Johnstone FD. Smoke screen around the fetus. Lancet 1990; 335: 361.
72. Haworth JC, Ellestad-Sayed JJ, King J et al. Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake. Am J Obstet Gynecol 1980; 137: 719–23.
73. Blair PS, Fleming PJ, Bensley D et al. Smoking and sudden infant deathsyndrome: results from 1993–5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J 1996; 313: 195–8.
________________________________________________
2. Shafey O, Eriksen MP, Ross H et al. The tobacco atlas, 3rd edn. Atlanta, GA: American Cancer Society and World Lung Foundation. 2009.
3. Centers for Disease Control and Prevention, Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. State Prenatal Smoking Databook, 1999. CDC, 2002; p. 14–7.
4. Kirkland SA, Dodds LA, Brosky G. The natural history of smoking during pregnancy among women in Nova Scotia. CMAJ 2000; 163: 281–2.
5. Kilbane S, Knudston E, Vesha K. Smoking cessation in women. Prim. Care Update Obstet Gynecol 2002; 9: 164–8.
6. American College of Obstetricians and Gynecologists. Smoking and Women’s Health. ACOG Educational Bulletin 240. Washington, DC: ACOG, 1997.
7. Fildinq JE. Smoking and women: Tragedy of the majority. New Engl J Med 2006; 317: 1343–5.
8. Kamardina T.V. Sovremennoe sostoianie problemy tabakokureniia i vozmozhnye puti ee resheniia. Obshchestvennoe zdorov'e i profilaktika zabolevanii. 2004; 5: 46. [in Russian]
9. Öberg M, Woodward A, Jaakkola MS et al. Global estimate of the burden of disease from second-hand smoke. Geneva, World Health Organization, 2010.
10. Kuzina O.A., Shchetinina Iu.S., Zinchenko E.A. K probleme kureniia pri beremennosti. Teoriia i praktika aktual'nykh issledovanii. 2016; 11: 119–26. [in Russian]
11. Parran TV. The physician’s role in smoking cessation. J Respir Dis 1998; 19: S6–12.
12. Rodgman A, Perfetti T. The chemical components of tobacco and tobacco smoke. Boca Raton, FL: CRC Press, 2009; p. 1483–784.
13. Talbot P, Riveles K. Smoking and reproduction: The oviduct as a target of cigarette smoke. Reprod Biol Endocrinol 2005; 3: 52.
14. Schick S, Glantz S. Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. Tob Control 2005; 14: 396–404.
15. Berlin I, Heilbronner C, Georgieu S et al. Newborns’ cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug Alcohol Depend 2010; 107: 250–2.
16. Lindbohm M-L, Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002; 28: 84–96.
17. Wu FY, Chiu HT, Wu HDI et al. Comparison of urinary and plasma cotinine levels during the three trimesters of pregnancy. Paediatr Perinatal Epidemiol 2008; 22: 296–301.
18. Kharrazi M, DeLorenze GN, Kaufman FL et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 2004; 15: 660–70.
19. Weinberg CR, Wilcox AJ, Baird DD. Reduced fecundability in women with prenatal exposure to cigarette smoking. Am J Epidemiol 1989; 129: 1072–8.
20. Jensen TK, Henriksen TB, Hjollund NHI et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998; 148: 992–7.
21. Hull MGR, North K, Taylor H et al. Delayed conception and active and passive smoking. Fertil Steril 2000; 74: 725–33.
22. Daling JR. Cigarette smoking and primary tubal infertility. In Smoking and Reproductive Health. Ed by: M.J.R.Littleton. MA, PSG Publishers. 1987; p. 40–6.
23. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 19: S81–S86.
24. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch. B Cell Pathol Incl Mol Patho 1991; 60: 365–72.
25. Salmasi G, Grady R, Jones J et al. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol 2010; 89: 423–1.
26. Sidorova I.S., Makarov I.O. Kliniko-diagnosticheskie aspekty fetoplatsentarnoi nedostatochnosti. M.: MIA, 2005. [in Russian]
27. Shchegolev A.I. Sovremennaia morfologicheskaia klassifikatsiia povrezhdenii platsenty. Akusherstvo i ginekologiia. 2016; 4: 16–23. [in Russian]
28. Gryzunova E.M., Sovershaeva S.L., Solov'ev A.G. i dr. Sostoianie gemodinamiki v sisteme “mat' – platsenta – plod” u kuriashchikh beremennykh. Ekologiia cheloveka. 2016; 9: 15–20. [in Russian]
29. Bureau MA, Monette J, Shapcott D et al. Carboxy haemoglobin concentration in fetal cord blood and in blood of mothers who smoked during labor. Pediatrics 1982; 69: 371–3.
30. Mayhew TM, Jackson MR, Haas JD. Oxygen diffusive conductances of human placentae from term pregnancies at low and high altitudes. Placenta 1990; 11: 493–503.
31. Bush G, Mayhew TM, Abramovich DR et al. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 2000; 21: 247–56.
32. Van der Velde WJ, Copius-Peereboom Stegman JH, Treffers PE, James J. Structural changes in the placenta of smoking mothers: a quantitative study. Placenta 1983; 4: 231–40.
33. Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers. Br J Obstet Gynaecol 1989; 96: 907–15.
34. Larsen LG, Clausen HV, Jønsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 2002; 186: 531–7.
35. Zhao H, Wu L, Wang Y et al. Nicotine promotes vascular endothelial growth factor secretion by human trophoblast cells under hypoxic conditions and improves the proliferation and tube formation capacity of human umbilical endothelial cells. Reprod Bio Med Online 2017; 34: 406–13.
36. Fan X, Rai A, Kambham N et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 2014; 124: 4941–52.
37. Pavlov K.A., Dubova E.A., Shchegolev A.I. Fetoplatsentarnyi angiogenez pri normal'noi beremennosti: rol' platsentarnogo faktora rosta i angiopoetinov. Akusherstvo i ginekologiia. 2010; 6: 10–5. [in Russian]
38. Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 2007; 197 (363): e1–e5.
39. Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000; 57: 207–13.
40. Wei J, Liu CX, Gong TT et al. Cigarette smoking during pregnancy and pre-eclampsia risk: a systematic review and meta-analysis of prospective studies. Oncotarget 2015; 6: 43667–78.
41. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010; 5: 1254–9.
42. Mayhew TM, Ohadike C, Baker PN et al. Stereological investigation of placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. Placenta 2003; 24: 219–26.
43. Shchegolev A.I., Dubova E.A., Pavlov K.A. i dr. Morfometricheskaia kharakteristika terminal'nykh vorsin platsenty pri preeklampsii. Biul. eksperim. biologii i meditsiny. 2012; 7: 104–7. [in Russian]
44. Vodneva D.N., Romanova V.V., Dubova E.A. i dr. Kliniko-morfologicheskie osobennosti rannei i pozdnei preeklampsii. Akusherstvo i ginekologiia. 2014; 2: 35–40.
[in Russian]
45. Shchegolev A.I., Liapin V.M., Tumanova U.N. i dr. Gistologicheskie izmeneniia platsenty i vaskuliarizatsiia ee vorsin pri rannei i pozdnei preeklampsii. Arkhiv patologii. 2016; 1: 13–8. [in Russian]
46. Sabra S, Gratacós E, Roig MDG. Smoking-induced changes in the maternal immune, endocrine, and metabolic pathways and their impact on fetal growth: A topical review. Fetal Diagn Ther 2017; 41; 241–50.
47. Hayashi K, Matsuda Y, Kawamichi Y et al. Smoking during pregnancy increases risks of various obstetric complications: A case-cohort study of the Japan Perinatal Registry Network Database. J Epidemiol 2011; 21: 61–6.
48. Hammoud AO, Bujold E, Sorokin Y et al. Smoking in pregnancy revisited: Findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856–63.
49. Comeau J, Shaw L, Marcell C, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983; 61: 577–80.
50. McShane P, Heyl P, Epstein M. Maternal and perinatal morbidity resulting from placental previa. Obstet Gynecol 1985; 65: 176–82.
51. Shchegolev A.I., Tumanova U.N., Frolova O.G. Regional'nye osobennosti mertvorozhdaemosti v Rossiiskoi Federatsii. Aktual'nye voprosy sudebno-meditsinskoi ekspertizy i ekspertnoi praktiki v regional'nykh biuro sudebno-meditsinskoi ekspertizy na sovremennom etape. Riazan', 2013; s. 163–9. [in Russian]
52. Hung TH, Hsieh CC, Hsu JJ et al. Risk factors for placenta previa in an Asian population. Int J Gynaecol Obstet 2007; 97: 26–30.
53. Thomas AG, Alvarez M, Friedman FJr et al. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 1994; 84: 58–60.
54. Matsuda Y, Hayashi K, Shiozaki A et al. Comparison of risk factors for placental abruption and placenta previa: case-cohort study. J Obstet Gynaecol Res 2011; 37: 538–46.
55. Shobeiri F, Jenabi E. Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 2017; 30: 2985–90.
56. Krohn M, Voigt L, McKnight B et al. Correlates of placental abruption. Br J Obstet Gynaecol 1987; 94: 333–40.
57. Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Gipoksiia kak prichina mertvorozhdaemosti v Rossiiskoi Federatsii. Zdorov'e, demografiia, ekologiia finno-ugorskikh narodov. 2014; 3: 96–8. [in Russian]
58. Tumanova U.N., Shuvalova M.P., Shchegolev A.I. Rol' prezhdevremennoi otsloiki platsenty v geneze rannei neonatal'noi smerti. Neonatologiia: novosti, mneniia, obuchenie. 2016; 4: 70–5. [in Russian]
59. Meyer M, Tonascia J. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol 1976; 1103: 464–76.
60. Shubert J, Diss E, Iams J. Etiology of preterm premature rupture of the membranes. Obstet Gynecol Clin North Am 1992; 19: 251–63.
61. Hadley C, Main D, Gabbe S. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990; 7: 374–9.
62. Meyer M, Tonascia J. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977; 128: 494–502.
63. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol 1998; 179: 1051–5.
64. Semenova T.V., Arzhanova O.N., Bespalova O.N. i dr. Osobennosti techeniia beremennosti i iskhodov rodov pri tabakokurenii. Zhurn. akusherstva i zhenskikh boleznei. 2014; 2: 50–8. [in Russian]
65. Klesges LM, Murray DM, Brown JE et al. Relations of cigarette smoking and dietary antioxidants with placental calcification. Am J Epidemiol 1998; 147: 127–35.
66. Marana HRC, Andrade JM, Martins GA et al. A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynecol Obstet 1998; 61: 21–7.
67. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: a light and electron microscopic study. Placenta 1982; 3: 243–56.
68. Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother. A quantitative and ultrastructural study. Pathol Res Pract 1994; 190: 656–67.
69. Salafia CM, Zhang J, Charles AK et al. Prenatal characteristics and birthweight. Paediatr Perinatal Epidemiol 2008; 22: 229–39.
70. Ganer Herman H, Miremberg H, Nini N et al. The effects of maternal smoking on pregnancy outcome and placental histopathology lesions. Reprod Toxicol 2016; 65: 24–8.
71. Johnstone FD. Smoke screen around the fetus. Lancet 1990; 335: 361.
72. Haworth JC, Ellestad-Sayed JJ, King J et al. Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake. Am J Obstet Gynecol 1980; 137: 719–23.
73. Blair PS, Fleming PJ, Bensley D et al. Smoking and sudden infant deathsyndrome: results from 1993–5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J 1996; 313: 195–8.
Авторы
А.И.Щеголев*1,2, У.Н.Туманова2, О.Д.Мишнёв2
1. ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова» Минздрава России. 117997, Россия, Москва, ул. Академика Опарина, д. 4;
2. ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1.
*ashegolev@oparina4.ru
1. V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4;
2. N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*ashegolev@oparina4.ru
1. ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова» Минздрава России. 117997, Россия, Москва, ул. Академика Опарина, д. 4;
2. ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1.
*ashegolev@oparina4.ru
________________________________________________
1. V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4;
2. N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*ashegolev@oparina4.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.